Associated Retinal Consultants, P.C.

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Macular degeneration4 trials

Phase

• Phase 22 trials
• Phase 32 trials

Status

• Active, not recruiting2 trials
• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Jaeb Center for Health Research1 trial
• Janssen Research & Development, LLC1 trial
• Ocular Therapeutix, Inc.1 trial
• ONL Therapeutics1 trial

Running trials

• Recruiting

  Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

  NCT06659445· Phase 2· ONL Therapeutics· Source

  Contact: Study Coordinator

• Active, not recruiting

  Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration

  NCT06495918· Phase 3· Ocular Therapeutix, Inc.· Source

• Active, not recruiting

  Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD

  NCT05904028· Phase 3· Jaeb Center for Health Research· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Macular degeneration1 recruiting

Closed trials

• Completed

  A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  NCT05811351· Phase 2· Janssen Research & Development, LLC· Source